GlassScriptPhysician profile
Allison Rose Mcgrath
NPI 1578309456
$1,704.53
in general payments reported to CMS, 2019-2025
19 companies · $1,359 in 2025
The $1,359 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $345 · 2025: $1,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $354.33 | 2024-2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $345.48 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $266.93 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $152.88 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.02 | 2024-2025 | Jardiance, Synjardy, Tradjenta |
| Exact Sciences Corporation | $71.44 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $66.83 | 2025 | |
| Lnhc, INC | $64.65 | 2025 | Zelsuvmi |
| Pfizer INC. | $46.35 | 2025 | |
| Sanofi-Aventis U.S. LLC | $38.74 | 2024 | |
| Merck Sharp & Dohme LLC | $33.79 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Phathom Pharmaceuticals, INC. | $32.86 | 2024 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $29.60 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.03 | 2025 | Xifaxan |
| Axsome Therapeutics, INC. | $21.31 | 2025 | Auvelity |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $19.91 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Collegium Pharmaceutical, INC. | $18.41 | 2025 | Xtampza |
| Vanda Pharmaceuticals INC. | $17.38 | 2025 | Fanapt |
| Bavarian Nordic A/S | $14.59 | 2025 | Vivotif |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Mcgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.